Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01069991 · ClinicalTrials.gov registry record · Phase 2

Asthma Self-Management For Adolescents

A Phase 2 study of Asthma, sponsored by Columbia University.

Completed
Registry status
Phase 2
Development phase
345
Enrollment target
1
Study location

NCT01069991: Completed Phase 2 study of Asthma, sponsored by Columbia University.

NCT01069991 is a Phase 2 study of Asthma that has completed, run by Columbia University. The registered enrollment target is 345 participants, below the 1,562-participant average among 374 other Asthma trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01069991, a Phase 2 study of Asthma, has completed, sponsored by Columbia University.

COMPLETED
Registry status
Phase 2
Development phase
345 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to help adolescents with asthma learn to control their illness and live without restrictions. We hypothesize that an intensive school-based asthma education program for students in 9th and 10th grade who have persistent asthma, together with asthma education for their primary care physicians, will improve the students' health status, quality of life, and ability to control their asthma through self-management.

Conditions Studied

Interventions

  • BEHAVIORAL Wait list control group
  • BEHAVIORAL Patient education group

Study Locations (1)

New York

  • Columbia University Medical Center - New York

Trial Details

FieldValue
Enrollment Target 345 participants
Start Date 2002-01
Est. Completion 2007-02
Phase Phase 2
Columbia University

958 total trials

What the finished NCT01069991 record still lists

NCT01069991 is an interventional study that assigns participants to a tested intervention. The registered 345 participants enrollment target is mid-sized for trials with a published cap, below the 1,562-participant average among 374 other Asthma trials with a reported enrollment target (78% lower).

The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 2 interventions - of which Wait list control group is the first listed.

NCT01069991 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT01069991 about?

NCT01069991 is a clinical study titled "Asthma Self-Management For Adolescents". The goal of this study is to help adolescents with asthma learn to control their illness and live without restrictions. We hypothesize that an intensive school-based asthma education program for students in 9th and 10th grade who have persistent asthma, together with asthma education for their prima...

What is the current status of trial NCT01069991?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 345 participants. The study started on 2002-01. Estimated completion is 2007-02.

What conditions does trial NCT01069991 study?

This clinical trial studies the following conditions: Asthma.

What interventions are being tested in trial NCT01069991?

The interventions under investigation include: Wait list control group (BEHAVIORAL), Patient education group (BEHAVIORAL).

Who is sponsoring clinical trial NCT01069991?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01069991 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Asthma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01069991's enrollment target sits among peer trials

345 107th of 374 higher than 267 of 374 other Asthma trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Asthma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03972657 · 345 participants · Phase 1

    A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors

  • NCT05107674 · 345 participants · Phase 1

    A Study of NX-1607 in Adults With Advanced Malignancies

  • NCT05700279 · 345 participants · NA

    Preventing the Development of Chronic Pain: Treating PTSD at Acute Pain Onset

  • NCT05781100 · 345 participants · NA

    Investigating Baby Behavior and Family Technology Use Study

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01069991, the US trial registry maintained by the National Library of Medicine. NCT01069991 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.